Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

Yue Chen; Yu-ying Xu; Hai-jun Jiang; Lei Wang; Jia-wei Zhai; Tong Zhang; Yu-fei Yang

doi:10.1007/s11655-022-3676-7

Your Location：

Home >

Browse articles >

Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

Updated：2022-05-13

- Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
- Chinese Journal of Integrative Medicine Pages: 1-6
- Affiliations：
- Author bio：
- Funds：
  
  Supported by National Administration of Traditional Chinese Medicine: Qihuang Scholar (No. 02045004) and Collaborative Pilot Project of Clinical Traditional Chinese and Western Medicine for Major and Difficult Diseases in 2019 (No. 070030003),Conflict of Interest,The authors declare that there are no conflicts of interest regarding the publication of this paper.,Author Contributions,Chen Y wrote the manuscript and was involved in the extraction of data, the statistical analysis of data and the follow-up of the patients. This project was initiated and developed by Yang YF, Xu YY and Jiang HJ. Yang YF was involved in the design of the study and manuscript revision and review. Xu YY and Jiang HJ were involved in the design of the study, literature research and the follow-up of the patients. Wang L was responsible for the follow-up of the patients. Zhai JW was responsible for the follow-up of the patients and data checking. Zhang T was involved in manuscript revision and review. All authors read and approved the final manuscripts.
- DOI：10.1007/s11655-022-3676-7
  CLC：
Scan for full text
Yue Chen, Yu-ying Xu, Hai-jun Jiang, et al. Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction. [J/OL]. 1-6(0)
DOI：

Yue Chen, Yu-ying Xu, Hai-jun Jiang, et al. Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction. [J/OL]. 1-6(0) DOI： 10.1007/s11655-022-3676-7.

摘要

Abstract

关键词

Keywords

references

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of Jianpi Bushen Sequential Formula on Adjuvant Chemotherapy of Colon Cancer: Study Protocol for a Randomized Controlled Trial

Related Author

No data

Related Institution

Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medicine Sciences, Beijing, China;Centre for Evidence-Based Chinese Medicine, Beijing University of traditional Chinese Medicine, Beijing, China;Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰